Deferred cytoreductive nephrectomy among patients with newly diagnosed metastatic renal cell carcinoma treated initially with sunitinib.

被引:0
|
作者
Bhindi, Bimal
Graham, Jeffrey
Wells, Connor
Donskov, Frede
Pasini, Felice
Lee, Jae-Lyun
Basappa, Naveen S.
Hansen, Aaron Richard
Wood, Lori
Kollmannsberger, Christian K.
Kanesvaran, Ravindran
Yuasa, Takeshi
Ernst, D. Scott
Srinivas, Sandy
Rini, Brian I.
Bowman, I. Alex
Pal, Sumanta K.
Choueiri, Toni K.
Heng, Daniel Yick Chin
机构
[1] Univ Calgary, Calgary, AB, Canada
[2] Univ Manitoba, Winnipeg, MB, Canada
[3] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
[4] Aarhus Univ Hosp, Dept Oncol, Aarhus, Denmark
[5] S Maria della Misericordia Hosp, Dept Oncol, ULSS 18, Rovigo, Italy
[6] Asan Med Ctr, Seoul, South Korea
[7] Univ Ulsan, Coll Med, Seoul, South Korea
[8] Cleveland Clin, Cleveland, OH 44106 USA
[9] Princess Margaret Canc Ctr, Toronto, ON, Canada
[10] Dalhousie Univ, Halifax, NS, Canada
[11] BC Canc Vancouver Canc Ctr, Vancouver, BC, Canada
[12] Natl Canc Ctr Singapore, Singapore, Singapore
[13] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan
[14] London Hlth Sci Ctr, London Reg Canc Program, Dept Oncol, Div Med Oncol, London, ON, Canada
[15] Univ Western Ontario, London, ON, Canada
[16] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA
[17] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[18] UT Southwestern Med Ctr, Dallas, TX USA
[19] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
[20] Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA
[21] Harvard Med Sch, Boston, MA 02115 USA
关键词
D O I
10.1200/JCO.2019.37.15_suppl.4578
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4578
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Deferred cytoreductive nephrectomy in the management of metastatic renal cell carcinoma: A systematic review and meta-analysis
    Britton, Cameron J.
    Andrews, Jack R.
    Wallis, Christopher J. D.
    Sharma, Vidit
    Leibovich, Bradley C.
    Thompson, R. Houston
    Boorjian, Stephen A.
    Bhindi, Bimal
    Costello, Brian A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (03) : 125 - 136
  • [42] Elective Cytoreductive Nephrectomy After Checkpoint Inhibitor Immunotherapy in Patients With Initially Unresectable Metastatic Clear Cell Renal Cell Carcinoma
    Reimers, Melissa A.
    Figenshau, Robert S.
    Kim, Eric H.
    Tucker, Julie
    Kasten, Nicole
    Khan, Adeel S.
    Hanneken, Jan M.
    Smith, Zachary L.
    Hsieh, James J.
    CLINICAL GENITOURINARY CANCER, 2020, 18 (05) : 361 - 366
  • [43] Impact of pretreatment C-reactive protein on overall survival for patients with metastatic renal cell carcinoma treated with sunitinib.
    Yasuda, Yosuke
    Saito, Kazutaka
    Sukegawa, Gen
    Tanaka, Hajime
    Ito, Masaya
    Kitsukawa, Shinichi
    Yuasa, Takeshi
    Urakami, Shinji
    Yamamoto, Shinya
    Takahashi, Shunji
    Fukui, Iwao
    Yonese, Junji
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [44] Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib
    Rini, Brian I.
    Tamaskar, Ila
    Shaheen, Phillip
    Salas, Renee
    Garcia, Jorge
    Wood, Laura
    Reddy, Sethu
    Dreicer, Robert
    Bukowski, Ronald M.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (01): : 81 - 83
  • [45] Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy
    Hahn, Andrew W.
    Kotecha, Ritesh R.
    Viscuse, Paul V.
    Pieretti, Alberto C.
    Wiele, Andrew J.
    Jonasch, Eric
    Lee, Chung-Han
    Gao, Jianjun
    Zurita, Amado J.
    Shah, Amishi Y.
    Campbell, Matthew T.
    Sharma, Padmanee
    Motzer, Robert J.
    Russo, Paul
    Wood, Christopher G.
    Tannir, Nizar M.
    Voss, Martin H.
    Karam, Jose A.
    Hakimi, A. Ari
    Msaouel, Pavlos
    EUROPEAN UROLOGY FOCUS, 2023, 9 (05): : 734 - 741
  • [46] EXPRESSION OF MOLECULAR MARKERS IN RADICAL NEPHRECTOMY SPECIMENS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH SUNITINIB
    Terakawa, T.
    Miyake, H.
    Masto, F.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 232 - 232
  • [47] Prognostic value of the Glasgow Prognostic Score for patients with metastatic renal cell carcinoma treated by cytoreductive nephrectomy
    Fukuda, Hironori
    Takagi, Toshio
    Kondo, Tsunenori
    Yoshida, Kazuhiko
    Shimizu, Satoru
    Nagashima, Yoji
    Tanabe, Kazunari
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (03) : 539 - 546
  • [48] Prognostic value of the Glasgow Prognostic Score for patients with metastatic renal cell carcinoma treated by cytoreductive nephrectomy
    Hironori Fukuda
    Toshio Takagi
    Tsunenori Kondo
    Kazuhiko Yoshida
    Satoru Shimizu
    Yoji Nagashima
    Kazunari Tanabe
    International Journal of Clinical Oncology, 2018, 23 : 539 - 546
  • [49] PROGNOSTIC VALUE OF THE GLASGOW PROGNOSTIC SCORE FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH CYTOREDUCTIVE NEPHRECTOMY
    Fukuda, Hironori
    Takagi, Toshio
    Kondo, Tsunenori
    Yoshida, Kazuhiko
    Shimizu, Satoru
    Nagashima, Yoji
    Tanabe, Kazunari
    JOURNAL OF UROLOGY, 2018, 199 (04): : E490 - E490
  • [50] Performing Cytoreductive Nephrectomy following Targeted Sunitinib Therapy for Metastatic Renal Cell Carcinoma: A Surgical Perspective
    Shaw, Greg L.
    Hussain, Mahreen
    Nair, Rajesh
    Bycroft, John
    Beltran, Luis
    Green, James S. A.
    Powles, Thomas
    Peters, John L.
    UROLOGIA INTERNATIONALIS, 2012, 89 (01) : 83 - 88